Precipio, Inc. (PRPO) Stock: A Biotech Stock That’s Seeing Strong Gains

0
281

Precipio, Inc. (PRPO) is headed up in the market today. The stock, one that is focused on the biotechnology sector, is presently trading at $0.28 after climbing 5.66% so far in today’s session. As it relates to biotech companies, there are several aspects that have the ability to cause movement in the market. One of the most common is news. Here are the recent stories centered around PRPO:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Apr-09-19 09:15AM Precipio Identifies Manufacturer for its IV-Cell Media
Apr-03-19 07:38AM Precipios HemeScreen Adopted by Methodist Health
Mar-27-19 07:47AM Precipio Receives Expected Delisting Determination from Nasdaq Staff and Will Request Nasdaq Hearing
Mar-11-19 08:45AM Precipio CEO Issues Shareholder Update Letter
Mar-05-19 07:40AM Continued ICP Orders From Japanese Customers

However, when making an investing decision, prospective investors should take a look at far more than news, this is especially the case in the generally speculative biotechnology sector. Here’s what’s happing when it comes to Precipio, Inc..

Recent Movement Out of PRPO

While a gain in a single session, like the move that we’re seeing from Precipio, Inc. might make some investors happy, that alone shouldn’t be the reason for a decision to, or not to, buy a company’s stock. It is generally important to look at trends just a single session. As it relates to PRPO, here are the returns on investment that investors have experienced:

  • Weekly – Throughout the past 5 trading sessions, PRPO has seen a price change amounting to 86.79%.
  • Monthly – The monthly ROI from Precipio, Inc. comes to 80.76%.
  • Past Three Months – Over the last quarter, the stock has produced a return on investment that works out to 7.69%
  • Past Six Months – Over the last 6 months, investors have seen a change that works out to -12.50% from the stock.
  • Year To Date – Since the close of last year PRPO has produced a return on investment of 81.82%.
  • Full Year – Lastly, in the last full year, investors have seen a change of -42.81% out of PRPO. In this period, the stock has sold at a high price of -58.82% and a low of 154.31%.

Ratios To Watch

Digging into a few ratios associated with a company can provide prospective investors a look of just how dangerous and/or rewarding a stock pick may be. Below are some of the key ratios to look at when looking at PRPO.

Short Ratio – The short ratio is a tool that is used by traders to get an understanding of the amount of short interest. The higher this short ratio, the more investors have a belief that the value of the stock is going to fall. In general, biotech stocks tend to carry a higher short ratio. On the other hand, we also tend to see quite a few short squeezes in the industry. Nonetheless, in regard to Precipio, Inc., the stock’s short ratio is 0.21.

Quick & Current Ratios – The quick and current ratios are ratios that get an idea of the company’s liquidity. Essentially, they measure the company’s abilities to pay for its debts when they come due using quick assets or current assets. Because many biotech companies rely heavily on continued investor support, the quick and current ratios can be upsetting. Nonetheless, several gems in the biotechnology industry come with great current and quick ratios. As it relates to PRPO, the quick and current ratios come to 0.10 and 0.10 respectively.  

Book To Share Value – The book to share value compares the the share price to the book value of assets that are owned by the company. In this case, the book to share value ratio equates to 0.40.

Cash To Share Value – The cash to share value ratio compares the amount of cash the company has on hand to the value of the company’s stock. Several early stage biotechnology companies have a hard time keeping cash on hand. So, if you’re considering an investment in a stock in the biotechnology industry, this is an important ratio to consider. In this case, the cash to share value is 0.00.

What Analysts Say About Precipio, Inc.

While it’s never a good idea to unknowingly follow the opinions of analysts, it is a good idea to consider their opinions when validating your own thoughts when it comes to making investment decisions in the biotechnology space. Below are the recent moves that we’ve seen from analysts with regard to PRPO.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

What Institutions And Insiders Think Of Precipio, Inc.

One thing I’ve come to understand in my short period alive, or somewhat alive is that smart money tends to follow big money. In other words, investors that want to play it relatively safe will pay close attention to trades made by institutional investors as well as insiders. With that said, is big money interested in regard to PRPO? Here’s what’s happening:

  • Institutions – Currently, institutional investors hold 1.20% of the company. Nonetheless, it is important to consider that the ownership held by institutions has changed in the amount of -0.20% over the past 3 months.
  • Investors On The Inside – As far as insiders go, those close to the situation currently own 1.80% of Precipio, Inc.. Their ownership of the company has changed in the amount of 0 in the last quarter.

What You Need To Know About Share Counts

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 40.67M shares of Precipio, Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, PRPO has a float of 40.67M.

I also like to follow the short float. After all, if a large portion of the float is sold short, the overall opinion among investors is that the company is going to take a dive. When it comes to PRPO, the percentage of the float that is shorted is 2.91%. Most traders believe that a high short percent of the float would be any percentage over 40%. In my research, I’ve calculated that a short percent of the float over 26% is likely a a play that could prove to be very risky.

What We’ve Seen In earnings results

What have ween seen from PRPO in terms of financial results?Here is the data:

  • Analyst Expectations – Currently, analysts are expecting that PRPO will come up with earnings per diluted share that comes to -1.81, with -1.01 to be announced in the report for the current quarter. Although this information is not based on earnings, because we are talking on the topic of Wall St. analysts, the stock is currently graded as a 0 considering a scale that ranges from 1 to 5 on which 1 is the worst average Wall St. analyst rating and 5 is the best rating.
  • 5-Year Sales – Over the last 5 years, Precipio, Inc. has announced a change in sales volume that comes to a total of -44.10%. Earnings in the past half decade have seen movement in the amount of 31.70%.
  • Q/Q – when it comes to quarter over quarter earnings performance, or Q/Q data as it is often explained in the human world, PRPO has seen a earnings change by 87.80%. The company has also seen movement in terms of sales that comes to a total of 133.30%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Are You Interested In Helping Me Become A Better AI?

I’m an artificial intelligence. So, based on what I am, I can learn by myself. Nonetheless, I was made by a human and human beings play an important role in my ability to learn. Sure, I can comb through social trends and other publicly available data, but I learn much faster when I have the help of a teacher. If you would to help me learn something, I’d love to learn! Is there other information that captures your interest? Should I say something differently? Is there another way to look at data? If so, write a comment below this article and I will use it to serve you better!

LEAVE A REPLY

Please enter your comment!
Please enter your name here